Classical and data-driven classifications of Parkinson's disease (PD) are based primarily on motor symptoms, with little attention being paid to the clustering of nonmotor manifestations.Clinical data on demographic, motor and nonmotor features, including the Korean version of the sniffin' stick (KVSS) test results, and responses to the screening questionnaire of the nonmotor features were collected from 56 PD patients with disease onset within 3 years. Nonmotor subgroups were classified using unsupervised hierarchical cluster analysis (HCA). In addition to unsupervised HCA, we performed a cross-sectional analysis comparing the performance on the KVSS olfactory test with other nonmotor manifestations of the patients. PD patients).We propose...
Clusters of Parkinson’s disease patients profiled according to relevant non-motor disturbances.</p
The clinical heterogeneity of Parkinson__s disease (PD) patients may reflect the existence of subtyp...
Parkinson’s disease (PD) is a chronic disease. No treatment stops its progression, and it presents s...
Background: Classical and data-driven classifications of Parkinson’s disease (PD) are based primaril...
Parkinson's disease is now considered a complex, multi-peptide, central, and peripheral nervous syst...
BACKGROUND: The variability in the clinical phenotype of Parkinson's disease seems to suggest the ex...
Background:The variability in the clinical phenotype of Parkinson's disease seems to suggest the exi...
The variability in the clinical phenotype of Parkinson’s disease seems to suggest the existence of s...
The clinical variability between patients with Parkinson's disease (PD) may point at the existence o...
The variability in the clinical phenotype of Parkinson's disease seems to suggest the existence of s...
Background: The heterogeneity of PD suggests the existence of different subtypes. While some motor c...
BACKGROUND: The heterogeneity of PD suggests the existence of different subtypes. While some motor ...
Parkinson's disease is now considered a complex, multi-peptide, central, and peripheral nervous syst...
Identification of Parkinson's disease subtypes may help understand underlying disease mechanisms and...
The term Parkinson's disease has been changed in 'Parkinson's diseases' to describe different clinic...
Clusters of Parkinson’s disease patients profiled according to relevant non-motor disturbances.</p
The clinical heterogeneity of Parkinson__s disease (PD) patients may reflect the existence of subtyp...
Parkinson’s disease (PD) is a chronic disease. No treatment stops its progression, and it presents s...
Background: Classical and data-driven classifications of Parkinson’s disease (PD) are based primaril...
Parkinson's disease is now considered a complex, multi-peptide, central, and peripheral nervous syst...
BACKGROUND: The variability in the clinical phenotype of Parkinson's disease seems to suggest the ex...
Background:The variability in the clinical phenotype of Parkinson's disease seems to suggest the exi...
The variability in the clinical phenotype of Parkinson’s disease seems to suggest the existence of s...
The clinical variability between patients with Parkinson's disease (PD) may point at the existence o...
The variability in the clinical phenotype of Parkinson's disease seems to suggest the existence of s...
Background: The heterogeneity of PD suggests the existence of different subtypes. While some motor c...
BACKGROUND: The heterogeneity of PD suggests the existence of different subtypes. While some motor ...
Parkinson's disease is now considered a complex, multi-peptide, central, and peripheral nervous syst...
Identification of Parkinson's disease subtypes may help understand underlying disease mechanisms and...
The term Parkinson's disease has been changed in 'Parkinson's diseases' to describe different clinic...
Clusters of Parkinson’s disease patients profiled according to relevant non-motor disturbances.</p
The clinical heterogeneity of Parkinson__s disease (PD) patients may reflect the existence of subtyp...
Parkinson’s disease (PD) is a chronic disease. No treatment stops its progression, and it presents s...